Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Periodontal pathogens are a diverse group of mostly Gram-negative anaerobic bacteria (including Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola and others) that live in dental plaque and contribute to the initiation, progression, and severity of periodontal diseases[2][5][6][7]. These bacteria interact synergistically to evade immune defenses, induce inflammation, and damage the tooth-supporting tissues. While essential for understanding periodontitis as an infectious process, "periodontal pathogens" is not a specific molecule or receptor, but a collective term for multiple disease-causing microbes. Diagnosis, prognosis, and treatment often hinge on detecting the presence and abundance of key pathogens within dental biofilms. Summary of key context: - "Periodontal pathogens" is a generic, collective term for many bacteria implicated in periodontal disease and is not a specific molecular drug target. - For pharmacological or mechanistic studies, individual bacteria within this group (e.g., Porphyromonas gingivalis) may be considered valid targets. - The group includes bacteria classified into "complexes" such as the "red complex"—Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola[2][6]. If structured target information is needed for drug discovery or biopharmaceutical contexts, individual organisms (e.g., Porphyromonas gingivalis) should be used in place of "periodontal pathogens".[2][6]
Antibacterial agents inhibit cell wall synthesis, protein synthesis, or metabolic activity of bacterial pathogens Antiseptics disrupt bacterial cell membranes and biofilms Host modulation therapies may alter host response to microbial challenge
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Periodontal pathogen.